Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Metagenomics Market, by Workflow
1.4.2 North America Metagenomics Market, by Product
1.4.3 North America Metagenomics Market, by Technology
1.4.4 North America Metagenomics Market, by Application
1.4.5 North America Metagenomics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Metagenomics Market
Chapter 4. North America Metagenomics Market by Workflow
4.1 North America Sequencing Market by Country
4.2 North America Pre-sequencing Market by Country
4.3 North America Data Analysis Market by Country
Chapter 5. North America Metagenomics Market by Product
5.1 North America Kits & Reagents Market by Country
5.2 North America Sequencing & Data Analytics Services Market by Country
5.3 North America Software Market by Country
Chapter 6. North America Metagenomics Market by Technology
6.1 North America Shotgun Sequencing Market by Country
6.2 North America 16S Sequencing Market by Country
6.3 North America Whole Genome Sequencing Market by Country
6.4 North America Others Market by Country
Chapter 7. North America Metagenomics Market by Application
7.1 North America Environmental Market by Country
7.2 North America Clinical Diagnostics Market by Country
7.3 North America Drug Discovery Market by Country
7.4 North America Biotechnology Market by Country
7.5 North America Food & Nutrition Market by Country
7.6 North America Others Market by Country
Chapter 8. North America Metagenomics Market by Country
8.1 US Metagenomics Market
8.1.1 US Metagenomics Market by Workflow
8.1.2 US Metagenomics Market by Product
8.1.3 US Metagenomics Market by Technology
8.1.4 US Metagenomics Market by Application
8.2 Canada Metagenomics Market
8.2.1 Canada Metagenomics Market by Workflow
8.2.2 Canada Metagenomics Market by Product
8.2.3 Canada Metagenomics Market by Technology
8.2.4 Canada Metagenomics Market by Application
8.3 Mexico Metagenomics Market
8.3.1 Mexico Metagenomics Market by Workflow
8.3.2 Mexico Metagenomics Market by Product
8.3.3 Mexico Metagenomics Market by Technology
8.3.4 Mexico Metagenomics Market by Application
8.4 Rest of North America Metagenomics Market
8.4.1 Rest of North America Metagenomics Market by Workflow
8.4.2 Rest of North America Metagenomics Market by Product
8.4.3 Rest of North America Metagenomics Market by Technology
8.4.4 Rest of North America Metagenomics Market by Application
Chapter 9. Company Profiles
9.1 Illumina, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Acquisition and Mergers:
9.2 Bio-Rad laboratories, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.3 Qiagen N.V.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.4 Takara Bio, Inc. (Takara Holdings Inc.)
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 Research & Development Expenses
9.5 Thermo Fisher Scientific, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 PerkinElmer, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 F. Hoffmann-La Roche Ltd.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.8 Oxford Expression Technologies Ltd.
9.8.1 Company Overview
9.8.2 Recent strategies and developments:
9.8.2.1 Product Launches and Product Expansions:
9.9 Novogene Co., Ltd.
9.9.1 Company Overview
9.9.2 Recent strategies and developments:
9.9.2.1 Product Launches and Product Expansions:
9.9.2.2 Geographical Expansions:
9.10. Promega Corporation
9.10.1 Company Overview
Unique Offerings 
